160 related articles for article (PubMed ID: 29504965)
21. Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes.
Matías-Guiu JA; Cabrera-Martín MN; Moreno-Ramos T; Valles-Salgado M; Fernandez-Matarrubia M; Carreras JL; Matías-Guiu J
J Neurol; 2015 Jun; 262(6):1463-72. PubMed ID: 25860346
[TBL] [Abstract][Full Text] [Related]
22.
Cho H; Kim HJ; Choi JY; Ryu YH; Lee MS; Na DL; Seo SW; Lyoo CH
Neurobiol Aging; 2019 Mar; 75():187-197. PubMed ID: 30594046
[TBL] [Abstract][Full Text] [Related]
23. Common and divergent neural correlates of anomia in amnestic and logopenic presentations of Alzheimer's disease.
Leyton CE; Hodges JR; Piguet O; Ballard KJ
Cortex; 2017 Jan; 86():45-54. PubMed ID: 27875715
[TBL] [Abstract][Full Text] [Related]
24. Static first-minute-frame (FMF) PET imaging after
Gómez-Grande A; Seiffert AP; Villarejo-Galende A; González-Sánchez M; Llamas-Velasco S; Bueno H; Gómez EJ; Tabuenca MJ; Sánchez-González P
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(4):211-217. PubMed ID: 36758828
[TBL] [Abstract][Full Text] [Related]
25. Clinical amyloid imaging in logopenic progressive aphasia.
Mendez MF; Sabodash V
Alzheimer Dis Assoc Disord; 2015; 29(1):94-6. PubMed ID: 23995816
[TBL] [Abstract][Full Text] [Related]
26. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
Fleisher AS; Chen K; Liu X; Roontiva A; Thiyyagura P; Ayutyanont N; Joshi AD; Clark CM; Mintun MA; Pontecorvo MJ; Doraiswamy PM; Johnson KA; Skovronsky DM; Reiman EM
Arch Neurol; 2011 Nov; 68(11):1404-11. PubMed ID: 21747008
[TBL] [Abstract][Full Text] [Related]
27. A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding.
Saint-Aubert L; Sagot C; Wallon D; Hannequin D; Payoux P; Nemmi F; Bezy C; Chauveau N; Campion D; Puel M; Chollet F; Pariente J
J Alzheimers Dis; 2014; 42(2):413-20. PubMed ID: 24898647
[TBL] [Abstract][Full Text] [Related]
28. The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy.
Dodich A; Cerami C; Inguscio E; Iannaccone S; Magnani G; Marcone A; Guglielmo P; Vanoli G; Cappa SF; Perani D
Neuroimage Clin; 2019; 24():102009. PubMed ID: 31795064
[TBL] [Abstract][Full Text] [Related]
29. [
Josephs KA; Martin PR; Botha H; Schwarz CG; Duffy JR; Clark HM; Machulda MM; Graff-Radford J; Weigand SD; Senjem ML; Utianski RL; Drubach DA; Boeve BF; Jones DT; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Whitwell JL
Ann Neurol; 2018 Mar; 83(3):599-611. PubMed ID: 29451323
[TBL] [Abstract][Full Text] [Related]
30. Clinical course of primary progressive aphasia: clinical and FDG-PET patterns.
Matias-Guiu JA; Cabrera-Martín MN; Moreno-Ramos T; García-Ramos R; Porta-Etessam J; Carreras JL; Matías-Guiu J
J Neurol; 2015 Mar; 262(3):570-7. PubMed ID: 25491078
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.
Bergeron D; Gorno-Tempini ML; Rabinovici GD; Santos-Santos MA; Seeley W; Miller BL; Pijnenburg Y; Keulen MA; Groot C; van Berckel BNM; van der Flier WM; Scheltens P; Rohrer JD; Warren JD; Schott JM; Fox NC; Sanchez-Valle R; Grau-Rivera O; Gelpi E; Seelaar H; Papma JM; van Swieten JC; Hodges JR; Leyton CE; Piguet O; Rogalski EJ; Mesulam MM; Koric L; Kristensen N; Pariente J; Dickerson B; Mackenzie IR; Hsiung GR; Belliard S; Irwin DJ; Wolk DA; Grossman M; Jones M; Harris J; Mann D; Snowden JS; Chrem-Mendez P; Calandri IL; Amengual AA; Miguet-Alfonsi C; Magnin E; Magnani G; Santangelo R; Deramecourt V; Pasquier F; Mattsson N; Nilsson C; Hansson O; Keith J; Masellis M; Black SE; Matías-Guiu JA; Cabrera-Martin MN; Paquet C; Dumurgier J; Teichmann M; Sarazin M; Bottlaender M; Dubois B; Rowe CC; Villemagne VL; Vandenberghe R; Granadillo E; Teng E; Mendez M; Meyer PT; Frings L; Lleó A; Blesa R; Fortea J; Seo SW; Diehl-Schmid J; Grimmer T; Frederiksen KS; Sánchez-Juan P; Chételat G; Jansen W; Bouchard RW; Laforce RJ; Visser PJ; Ossenkoppele R
Ann Neurol; 2018 Nov; 84(5):729-740. PubMed ID: 30255971
[TBL] [Abstract][Full Text] [Related]
32. Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.
Joshi AD; Pontecorvo MJ; Clark CM; Carpenter AP; Jennings DL; Sadowsky CH; Adler LP; Kovnat KD; Seibyl JP; Arora A; Saha K; Burns JD; Lowrey MJ; Mintun MA; Skovronsky DM;
J Nucl Med; 2012 Mar; 53(3):378-84. PubMed ID: 22331215
[TBL] [Abstract][Full Text] [Related]
33. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
34. High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia.
Ferrari C; Polito C; Berti V; Lombardi G; Lucidi G; Bessi V; Bagnoli S; Piaceri I; Nacmias B; Sorbi S
J Alzheimers Dis; 2019; 72(4):1089-1096. PubMed ID: 31683481
[TBL] [Abstract][Full Text] [Related]
35. Cholinergic depletion and basal forebrain volume in primary progressive aphasia.
Schaeverbeke J; Evenepoel C; Bruffaerts R; Van Laere K; Bormans G; Dries E; Tousseyn T; Nelissen N; Peeters R; Vandenbulcke M; Dupont P; Vandenberghe R
Neuroimage Clin; 2017; 13():271-279. PubMed ID: 28018854
[TBL] [Abstract][Full Text] [Related]
36. Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging.
Leyton CE; Villemagne VL; Savage S; Pike KE; Ballard KJ; Piguet O; Burrell JR; Rowe CC; Hodges JR
Brain; 2011 Oct; 134(Pt 10):3030-43. PubMed ID: 21908392
[TBL] [Abstract][Full Text] [Related]
37. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
[TBL] [Abstract][Full Text] [Related]
38. Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.
Lister-James J; Pontecorvo MJ; Clark C; Joshi AD; Mintun MA; Zhang W; Lim N; Zhuang Z; Golding G; Choi SR; Benedum TE; Kennedy P; Hefti F; Carpenter AP; Kung HF; Skovronsky DM
Semin Nucl Med; 2011 Jul; 41(4):300-4. PubMed ID: 21624563
[TBL] [Abstract][Full Text] [Related]
39. Phonologic errors as a clinical marker of the logopenic variant of PPA.
Leyton CE; Ballard KJ; Piguet O; Hodges JR
Neurology; 2014 May; 82(18):1620-7. PubMed ID: 24706011
[TBL] [Abstract][Full Text] [Related]
40. Enlarged perivascular spaces and florbetapir uptake in patients with intracerebral hemorrhage.
Raposo N; Planton M; Payoux P; Péran P; Albucher JF; Calviere L; Viguier A; Rousseau V; Hitzel A; Chollet F; Olivot JM; Bonneville F; Pariente J
Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2339-2347. PubMed ID: 31359110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
